OSUR OraSure Technologies Inc

OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Ronald H. Spair, COO & CFO, will speak to the investment community at the Roth 23rd Annual OC Growth Stock Conference in Dana Point, California. The conference will be simultaneously webcast over the Internet.

Mr. Spair is scheduled to speak March 14, 2011, at approximately 6:30 pm Eastern Time (3:30 pm Pacific Time). Interested investors can access the live webcast of the presentation by going to OraSure Technologies' web site, www.orasure.com, and clicking on the Investor Info link. A replay of the webcast will be available on OraSure Technologies' web site for seven days. Alternatively, you can access the live webcast of the presentation via the following link: http://www.wsw.com/webcast/roth24/osur/.

About OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. For more information on the Company, please go to www.orasure.com.

The OraSure Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6440

CONTACT: Ronald H. Spair
         Chief Financial Officer
         610-882-1820
         Investorinfo@orasure.com
         www.orasure.com